Axsome Therapeutics Cash from Operations (TTM) Insights

Axsome Therapeutics Inc (AXSM)

76.54 -0.82 (-1.05%) USD | NASDAQ | May 17, 16:00

76.54 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	-192.73M
December 31, 2023	-145.08M
September 30, 2023	-142.28M
June 30, 2023	-111.49M
March 31, 2023	-89.68M
December 31, 2022	-116.51M
September 30, 2022	-117.79M
June 30, 2022	-121.81M
March 31, 2022	-113.66M
December 31, 2021	-108.23M
September 30, 2021	-99.94M
June 30, 2021	-88.90M
March 31, 2021	-82.40M
December 31, 2020	-78.46M
September 30, 2020	-75.47M
June 30, 2020	-70.36M
March 31, 2020	-60.15M

Date	Value
December 31, 2019	-46.38M
September 30, 2019	-38.60M
June 30, 2019	-33.89M
March 31, 2019	-32.87M
December 31, 2018	-30.05M
September 30, 2018	-26.55M
June 30, 2018	-27.09M
March 31, 2018	-26.52M
December 31, 2017	-26.47M
September 30, 2017	-27.40M
June 30, 2017	-25.75M
March 31, 2017	-23.97M
December 31, 2016	-21.28M
September 30, 2016	-16.32M
June 30, 2016	-13.44M
March 31, 2016	-10.23M
December 31, 2015	-7.439M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-192.73M

Minimum

Mar 2024

-33.89M

Maximum

Jun 2019

-96.69M

Average

-94.81M

Median

Cash from Operations (TTM) Benchmarks